Corient Private Wealth
BSX icon

Corient Private Wealth’s Boston Scientific BSX Stock Holding History

Corient Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Buy
262,815
+76,212
+41% +$4.14M 0.01% 624
2026
Q1 		$11.6M Sell
186,603
-280,943
-60% -$22.5M 0.02% 574
2025
Q4 		$43.7M Buy
467,546
+248,748
+114% +$24.4M 0.03% 394
2025
Q3 		$21.2M Buy
218,798
+45,050
+26% +$4.67M 0.03% 381
2025
Q2 		$18.7M Sell
173,748
-13,885
-7% -$1.4M 0.02% 399
2025
Q1 		$18.9M Buy
187,633
+17,097
+10% +$1.72M 0.03% 398
2024
Q4 		$15.2M Buy
170,536
+2,097
+1% +$185K 0.03% 436
2024
Q3 		$14.1M Sell
168,439
-2,533
-1% -$200K 0.02% 480
2024
Q2 		$13.2M Buy
170,972
+12,087
+8% +$885K 0.02% 464
2024
Q1 		$10.9M Buy
158,885
+3,027
+2% +$195K 0.02% 505
2023
Q4 		$9.01M Sell
155,858
-22,948
-13% -$1.22M 0.02% 543
2023
Q3 		$9.44M Buy
178,806
+3,776
+2% +$198K 0.02% 494
2023
Q2 		$9.47M Buy
175,030
+16,506
+10% +$862K 0.02% 486
2023
Q1 		$7.93M Buy
158,524
+23,265
+17% +$1.1M 0.02% 469
2022
Q4 		$6.26M Buy
+135,259
New +$5.86M 0.02% 446

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Corient Private Wealth's BSX Position: Q2 2026 in Review

Corient Private Wealth increased its Boston Scientific (BSX) stake by 41% in Q2 2026, buying an estimated $4.14M and bringing the position to 262,815 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #624.

Corient Private Wealth first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $43.7M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Corient Private Wealth held 262,815 shares of Boston Scientific worth $11.2M as of Q2 2026.
  • Corient Private Wealth bought 76,212 Boston Scientific shares in Q2 2026, an estimated $4.14M.
  • Boston Scientific made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #624 holding.
  • Corient Private Wealth first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Boston Scientific position peaked at $43.7M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.